Lexicon Pharmaceuticals, Inc (LXRX) CEO Lonnel Coats on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/09/19
Lexicon Pharmaceuticals (LXRX) Q3 Earnings and Revenues Beat EstimatesZacks Investment Research • 11/07/19
Lexicon Pharmaceuticals (LXRX) to Report Q3 Results: Wall Street Expects Earnings GrowthZacks Investment Research • 10/31/19
Lexicon Pharmaceuticals Announces Poster Presentations at the NANETS Annual Multidisciplinary NET Medical SymposiumGlobeNewsWire • 10/02/19
Are Options Traders Betting on a Big Move in Lexicon Pharmaceuticals (LXRX) Stock?Zacks Investment Research • 09/23/19
Lexicon Pharmaceuticals to Present Sotagliflozin Clinical Data at the European Association for the Study of Diabetes 55th Annual MeetingGlobeNewsWire • 09/10/19
Lexicon Pharmaceuticals Announces Termination of Alliance and Settlement With SanofiGlobeNewsWire • 09/10/19
Lexicon Pharmaceuticals Inc (LXRX) President and CEO Lonnel Coats Bought $54,000 of SharesGuruFocus • 08/20/19
Lexicon Pharmaceuticals Inc. (LXRX) CEO Lonnel Coats on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/01/19
Why Cooper Tire & Rubber, Insperity, and Lexicon Pharmaceuticals Slumped TodayThe Motley Fool • 07/29/19
Lexicon's stock loses more than half its value after Sanofi's notice to end allianceMarket Watch • 07/29/19
Lexicon Pharmaceuticals (LXRX) May Report Negative Earnings: Know the Trend Ahead of Q2 ReleaseZacks Investment Research • 07/22/19
Lexicon Pharmaceuticals, Inc. (LXRX) CEO Lonnel Coats on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/01/19
Will Lexicon Pharmaceuticals (LXRX) Report Negative Q1 Earnings? What You Should KnowZacks Investment Research • 04/25/19